- Home
- APM vs SNES Comparison
APM vs SNES Comparison
Compare APM & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- SNES
- Stock Information
- Founded
- APM 2010
- SNES 2004
- Country
- APM United Kingdom
- SNES United States
- Employees
- APM N/A
- SNES N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- APM Health Care
- SNES Industrials
- Exchange
- APM Nasdaq
- SNES Nasdaq
- Market Cap
- APM 18.9M
- SNES 21.0M
- IPO Year
- APM 2018
- SNES 2016
- Fundamental
- Price
- APM $1.96
- SNES $4.86
- Analyst Decision
- APM
- SNES Strong Buy
- Analyst Count
- APM 0
- SNES 1
- Target Price
- APM N/A
- SNES $10.00
- AVG Volume (30 Days)
- APM 20.5M
- SNES 98.3K
- Earning Date
- APM 04-30-2025
- SNES 11-11-2025
- Dividend Yield
- APM N/A
- SNES N/A
- EPS Growth
- APM N/A
- SNES N/A
- EPS
- APM N/A
- SNES N/A
- Revenue
- APM N/A
- SNES $2,093,000.00
- Revenue This Year
- APM N/A
- SNES $130.53
- Revenue Next Year
- APM N/A
- SNES $22.87
- P/E Ratio
- APM N/A
- SNES N/A
- Revenue Growth
- APM N/A
- SNES 36.89
- 52 Week Low
- APM $0.46
- SNES $1.30
- 52 Week High
- APM $7.49
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- APM 52.30
- SNES 49.15
- Support Level
- APM $1.64
- SNES $4.84
- Resistance Level
- APM $2.65
- SNES $5.26
- Average True Range (ATR)
- APM 0.20
- SNES 0.27
- MACD
- APM -0.04
- SNES 0.01
- Stochastic Oscillator
- APM 31.68
- SNES 32.17
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.